naproxen sodium
Generic: naproxen sodium
Labeler: p & l development, llcDrug Facts
Product Profile
Brand Name
naproxen sodium
Generic Name
naproxen sodium
Labeler
p & l development, llc
Dosage Form
CAPSULE
Routes
Active Ingredients
naproxen sodium 220 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
59726-751
Product ID
59726-751_2a68267b-0fa0-4b09-b8a8-15f11aaa71f9
Product Type
HUMAN OTC DRUG
Marketing Category
ANDA
Application Number
ANDA202807
Marketing Start
2020-12-04
Marketing End
2026-12-31
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
59726751
Hyphenated Format
59726-751
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
naproxen sodium (source: ndc)
Generic Name
naproxen sodium (source: ndc)
Application Number
ANDA202807 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 220 mg/1
Packaging
- 1 BOTTLE, PLASTIC in 1 BOX (59726-751-20) / 20 CAPSULE in 1 BOTTLE, PLASTIC
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2a68267b-0fa0-4b09-b8a8-15f11aaa71f9", "openfda": {"upc": ["0359726751209"], "unii": ["9TN87S3A3C"], "rxcui": ["1112231"], "spl_set_id": ["3bd60171-c073-441a-8d59-c85efee69e07"], "manufacturer_name": ["P & L Development, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 BOX (59726-751-20) / 20 CAPSULE in 1 BOTTLE, PLASTIC", "package_ndc": "59726-751-20", "marketing_end_date": "20261231", "marketing_start_date": "20201204"}], "brand_name": "Naproxen Sodium", "product_id": "59726-751_2a68267b-0fa0-4b09-b8a8-15f11aaa71f9", "dosage_form": "CAPSULE", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "59726-751", "generic_name": "Naproxen Sodium", "labeler_name": "P & L Development, LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Naproxen Sodium", "active_ingredients": [{"name": "NAPROXEN SODIUM", "strength": "220 mg/1"}], "application_number": "ANDA202807", "marketing_category": "ANDA", "marketing_end_date": "20261231", "marketing_start_date": "20201204"}